Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · October 29, 2015

Empagliflozin as Adjunct to Metformin and Sulfonylurea

Diabetes Research and Clinical Practice

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Research and Clinical Practice
Empagliflozin as Add-On to Metformin Plus Sulphonylurea in Patients With Type 2 Diabetes
Diabetes Res. Clin. Pract. 2015 Oct 01;110(1)82-90, HU Haering, L Merker, AV Christiansen, F Roux, A Salsali, G Kim, T Meinicke, HJ Woerle, UC Broedl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading